NATIONAL STOCK EXCHANGE OF INDIA LIMITED DEPARTMENT : LISTING Download Ref. No.: NSE/CML/38218

Date : July 03, 2018

Circular Ref. No.: 0741 /2018 To All Members, Sub: Exclusively listed companies of De-recognized/Non-operational/exited Stock Exchanges placed in the Dissemination Board (DB). As per SEBI Circular No. SEBI/HO/MRD/DSA/CIR/P/2017/92 dated August 01, 2017 pertaining to action against Exclusively Listed Companies and its Promoters/Directors, it has been decided to freeze shares of the Directors, Promoters of the following company w.e.f. July 03, 2018, to the extent data available in the Exchange records or received from the concerned ROCs: Sr. No. Name of the Company 1 Aster Drugs & Pharmaceuticals Ltd The consequences of non-compliant, include the following:1. The non-compliant ELCs, its directors, its promoters and the companies which are promoted by any of them shall not be eligible to access the securities market for the purposes of raising capital till the promoters of such ELCs provide an exit option to the public shareholders. 2. The promoters and directors of non-compliant ELCs shall not be eligible to remain or become director of any listed company till the promoters of such non-complaint ELCs provide exit option to public shareholders. This is for your information please. For and on behalf of National Stock Exchange of India Limited

Kautuk Upadhyay Chief Manager Telephone No. 022-026598235/31

Fax No. -

Email Id -

Regd. Office: Exchange Plaza, Plot No. C/1, G-Block, Bandra-Kurla Complex, Bandra (E), Mumbai 400 051, India CIN: U67120MH1992PLC069769 Tel: +91 22 26598235/36 , 26598346, 26598459/26598458 Web site: www.nseindia .com